Published in:
Open Access
01-12-2014 | Case report
Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation
Authors:
Tobias Kammerer, Andres Beiras-Fernandez, Markus Rehm, Manfred Stangl, Markus Guba, Christian Kupatt-Jeremias, Florian Weis
Published in:
BMC Cardiovascular Disorders
|
Issue 1/2014
Login to get access
Abstract
Background
Kidney transplantation is the gold standard of therapy in patients with terminal renal insufficiency. Living donor transplantation is a well-established option in this field. Enlarging the donor’s pool implicates the acceptance of an increased rate of comorbidities. Among them, coronary artery disease is a growing problem. An increasing number of patients, undergoing living donation, receive antiplatelet therapies due to coronary disease.
Case presentation
Here we report about the perioperative treatment with a drug-eluting balloon in a patient with major cardiac risk factors who underwent kidney transplantation.
Conclusion
At the current time no recommendation can be given for the routine use of drug-eluting balloons.